It is also recognized that GALNT2 is a novel modulator of adipogenesis and related cellular phenotypes, thus becoming a potential target for tackling the epidemics of obesity and its devastating health consequences [14]. This evidence concerns the gene GALNT2 and obesity due to melanocortin 4 receptor deficiency.